Merck (NYSE: MRK) reported its fourth-quarter earnings for 2024, showcasing a mixed performance that has raised concerns among investors for…
Read More
Merck (NYSE: MRK) reported its fourth-quarter earnings for 2024, showcasing a mixed performance that has raised concerns among investors for…
Read More